WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its fiscal second quarter and six-months ended March 31, 2015 financial results before the U.S. markets open on May 7, 2015. Enanta management will host a conference call at 8:30 a.m. ET to discuss these results and Enanta’s research and development pipeline.
Help employers find you! Check out all the jobs and post your resume.
